Abstracts

Submit your abstract

The Abstract submission is closed. Only abstracts for symposia agreed with the scientific committee can be submitted.

The ISGE welcomes scientists to present their scientific works as Poster or Oral Presentations.

Apply for an #ISGE2024 scholarship

Submitting an abstract you will be able to apply to our scholarships!

Get ready to submit

Follow the guidelines and submit your abstract for Oral presentations, Poster Presentations or both

Present your research

Share your findings with the global community

Main topics
for abstracts

GYNECOLOGICAL ENDOCRINOLOGY
Polycystic ovary syndrome, Obesity, metabolic syndrome...
CONTRACEPTION
Long lasting contraception, Intrauterine contraceptives...
MEDICALLY ASSISTED PROCREATION
Fertility preservation, Reproduction, the Immune system and oxidative stress...
OBSTETRICS
Gestational hypertension, pre-eclampsia and eclampsia, Infectious diseases and pregnancy, Recurrent abortion...
GYNECOLOGY
Uterine myomas, medical and surgical management, Puberty and adolescent gynecology...
MENOPAUSE AND AGEING
Non-hormonal treatments for climacteric women, Steroid hormones and ageing...
GYNECOLOGICAL ONCOLOGY
Genes and gynecological cancers, Screenings for gynecological cancers...
THE BREAST
Hormones and the breast, Breast development and function, Hormones, breast cancer proliferation...
GYNECOLOGICAL SURGERY
Urinary incontinence, Laparoscopy, endometriosis and reproduction...
DIAGNOSIS
Long lasting contraception, Ultrasound in gynecology and obstetrics...
1 GYNECOLOGICAL ENDOCRINOLOGY
  • 1.1 Neuroendocrinology
  • 1.2 FSH and LH
  • 1.3 Prolactin and Hyperprolactinemia
  • 1.4 GnRH agonists and antagonists
  • 1.5 Steroid receptors
  • 1.6 Estrogens and SERM’s
  • 1.7 Progesterone, Progestins and SPRM’s
  • 1.8 Androgens and hyperandrogenisms
  • 1.9 Primary and secondary amenorrhea
  • 1.10 Polycystic ovary syndrome
  • 1.11 Insulin resistance
  • 1.12 Obesity, metabolic syndrome
  • 1.13 Pediatric and adolescent endocrinology
  • 1.14 Thyroid
  • 1.15 Endocrine disorders and women s health
  • 1.16 Endocrine disruptors
  • 1.17 Adrenal Gland
  • 1.18 Regulation of the HPG axis
  • 1.19 Pituitary and Pituitary Hormones
  • 1.20 Endocrine therapies in Transgenderism
2 CONTRACEPTION
  • 2.1 New compounds for Hormonal Contraception
  • 2.2 Non-contraceptive benefits of Hormonal Contraception
  • 2.3 Male contraception
  • 2.4 Emergency contraception
  • 2.5 Intrauterine and Vaginal contraception
  • 2.7 Contraception and adolescents
  • 2.8 Contraception and perimenopause
  • 2.9 Therapeutic uses of Hormonal Contraception
  • 2.10 Progestogens Only Contraception
3 MEDICALLY ASSISTED PROCREATION
  • 3.1 Implantation and Embryo development
  • 3.2 Stem cells and reproduction
  • 3.3 Mechanisms of follicle selection and development
  • 3.4 Immune system and oxidative stress in Reproduction
  • 3.5 The infertile couple
  • 3.6 Techniques in MAP
  • 3.7 Ovulation induction
  • 3.8 Ovarian hyperstimulation
  • 3.9 Endometriosis and MAP
  • 3.10 The anovulatory patient
  • 3.11 Endocrine disorders and MAP
  • 3.12 Adnexal diseases and MAP
  • 3.13 Fertility preservation
  • 3.14 Autologue and heterologue donation
  • 3.15 MAP and ethics
  • 3.16 MAP in premature ovarian insufficiency
  • 3.17 PGD/PGS
4 OBSTETRICS
  • 4.1 Abortion and Recurrent abortion
  • 4.2 Extra-uterine pregnancy
  • 4.3 Prenatal diagnosis
  • 4.4 Fetal medicine
  • 4.5 The placenta and the fetal membranes
  • 4.6 The thyroid and pregnancy
  • 4.7 Immunological disorders and pregnancy
  • 4.8 Endocrine disorders in pregnancy
  • 4.9 Neurodegenerative disorders in pregnancy
  • 4.10 Insulin resistance and obstetric diseases
  • 4.11 Obesity and fetal and maternal risks
  • 4.12 Pregnancy and lifestyle
  • 4.13 Preterm labor and delivery
  • 4.14 Gestational hypertension, pre-eclampsia and eclampsia
  • 4.15 Gestational Diabetes Mellitus
  • 4.16 Normal and abnormal intrauterine growth
  • 4.17 Infectious diseases and pregnancy
  • 4.18 Twin and multiple pregnancies
  • 4.19 Labor induction and Delivery
  • 4.20 Caesarean Section: pro and con
  • 4.21 Fetal origins of adult diseases
  • 4.22 Postpartum management of high risk pregnancies
  • 4.23 Breast Feeding
5 GYNECOLOGY
  • 5.1 Stem cells in gynecology
  • 5.2 Angiogenesis and gynecological diseases
  • 5.3 Puberty and adolescent gynecology
  • 5.4 Female sexual function and dysfunction
  • 5.5 Sexually transmitted diseases
  • 5.6 Hormones and gynecological disorders
  • 5.7 Endometrium and Endometrial regulation
  • 5.8 Abnormal uterine bleeding
  • 5.9 Pelvic pain
  • 5.10 Endometrial hyperplasia
  • 5.11 Endometriosis: genetics and hormones
  • 5.12 Medical and Surgical treatments for endometriosis
  • 5.13 Uterine myomas, medical and surgical management
  • 5.14 Adenomyosis
  • 5.15 Clinical management of adnexal cysts
  • 5.16 Uterine Malformations
  • 5.17 Vagina and Vulva
6 MENOPAUSE AND AGEING
  • 6.1 Menopausal Transition
  • 6.2 Steroid hormones and aging
  • 6.3 Brain Cells and hormone protection
  • 6.4 The climacteric syndrome
  • 6.5 Menopause, MHT and CVD
  • 6.6 Menopause, MHT and Cancers
  • 6.7 Menopause, MHT and neurodegenerative diseases
  • 6.8 Postmenopausal osteoporosis and MHT
  • 6.9 Bisphosphonates, PTH and the bone-forming agents
  • 6.10 Estrogens and SERM’s in MHT
  • 6.11 Progesterone, progestins and SPRM’s in MHT
  • 6.12 Androgen therapy
  • 6.13 Bio-identical treatments
  • 6.14 Non-hormonal treatments for climacteric women
  • 6.15 Sexual health and dysfunction in Menopause
  • 6.16 Phytoestrogens and Phyto-SERMs
  • 6.17 Plant extracts and steroid menopausal symptoms
  • 6.18 Neurokinins and Neurokinin receptor’s Agonist and Antagonist
7 GYNECOLOGICAL ONCOLOGY
  • 7.1 Genes and gynecological cancers
  • 7.2 Hormones and gynecological cancers
  • 7.3 Stem cells and gynecological malignancies
  • 7.4 Proteomics for cancer diagnosis and treatment
  • 7.5 Screenings and for gynecological cancers
  • 7.6 HPV and HPV vaccines
  • 7.7 Border-line and pre-tumoral lesions
  • 7.8 Clinical management of gynecological cancers
  • 7.9 Conservative approaches to gynecological cancers
  • 7.10 New concepts in radio/chemotherapy
  • 7.11 Hormonal therapies for gynecological cancers
  • 7.12 Pregnancy and cancers
8 THE BREAST
  • 8.1 Breast development and function
  • 8.2 Hormones and the breast
  • 8.3 Benign breast diseases, contraception and MHT
  • 8.4 Breast carcinogenesis
  • 8.5 Hormones, breast cancer proliferation and metastasis
  • 8.6 New prognostic and predictive factors
  • 8.7 Anti-estrogens, SERMs and aromatase inhibitors
  • 8.8 Oncological and aesthetic breast surgery
  • 8.9 Breast cancer and pregnancy
9 GYNECOLOGICAL SURGERY
  • 9.1 Vaginal approaches to pelvic diseases
  • 9.2 Urinary incontinence
  • 9.3 New techniques for pelvic floor defects correction
  • 9.4 Laparoscopic treatment of pelvic masses
  • 9.5 Laparoscopic surgery in endometriosis
  • 9.6 New treatments of uterine myomas
  • 9.7 Sentinel node biopsy in gynecological cancers
  • 9.8 Oncological applications of aparoscopy
  • 9.9 Robotic surgery in gynecology
  • 9.10 Multidisciplinary approach to the pelvic floor
  • 9.11 Reconstructive Surgery
10 DIAGNOSIS
  • 10.1 Ultrasound in gynecology and obstetrics
  • 10.2 Interventional ultrasound techniques
  • 10.3 Hysteroscopy
  • 10.4 Colposcopy
  • 10.5 Laparoscopy
  • 10.6 Tomography, Magnetic Resonance and other techniques

abstract guidelines

  • Registration for the Congress is not required to submit an abstract.
  • Each person is allowed to submit a maximum of two abstracts on the congress’ topics as presenting author: one oral presentation and one poster or, alternatively, two posters. There is no limit to the number of abstracts submitted as co-author.
  • It’s allowed to submit abstracts already presented in other conferences or Scientific Journals
  • Presenting authors of accepted abstracts are entitled to register at the special fee communicated along with the acceptance email.
  • Abstracts should be structured into the following sections if applicable: Context – Objective – Methods – Patient(s) – Intervention(s) – Main Outcome Measure(s) – Result(s) – Conclusions.
  • The abstract cannot be longer than 2500 characters including spaces, and must be plain text. It is not possible to include tables and images, but you may insert data in the text of the abstract.
  • Abstracts can only be submitted using the on-line form. Abstracts submitted via email are automatically discarded.
  • Submit you abstract following the online submission process and upload your file in the appropriate field.
  • Once accepted, abstract cannot be modified in any of its parts (authors, content and title)
  • Abstracts received after the deadline will not be accepted.
  • Presenting authors of accepted abstracts will be notified within 15 March 2024 whether their abstract is accepted.
  • The correctness of the authors’ personal details is entirely up to the responsibility of the author who has submitted the abstract.
  • The submitting author will be also responsible for all the communication (please make sure that a valid email is submitted).
  • The abstract submission indicates acknowledgement and consent for publication in the official program as well as in GREM Journal

CALENDAr OF DEADLINES

February 8 2024
DEADLINE FOR FCP SCHOLARSHIP

The FCP Scholarship is reseved to young researchers and provides free registration + accommodation. Check all the requirements to apply here.

*NEW DEADLINE*
February 29 2024
DEADLINE FOR ORAL PRESENTATIONS

The Scientific Committee will consider the abstracts not accepted as Oral Presentations for possible inclusion in the Poster Session.

March 14 2024
DEADLINE FOR POSTERS

Within March 18 2024
ACCEPTANCE

The submitted abstracts will be under a review process. After that, all the abstract submitters will be communicated whether their abstract is accepted. The acceptance letters will be sent between 5 and 18 March.

April 3 2024
REGISTRATION

Speakers whose abstracts have been accepted must complete their congress registration before April 3 2024 .

Submit your abstract

The accepted abstracts will be divided into Oral Presentations and Poster Session. Rules for presentation will be available after the acceptance in the account page.

The Oral Presentation Sessions

The Oral Presentation Sessions will be held at the Congress Venue.

The Poster Session

will be organized at the Congress Venue.
All the authors will be requested to bring their printed poster at the congress venue.